In this episode of the Applied Clinical Trials Brief, we spotlight a recent video interview in which Jon Walsh, founder and ...

With approval to proceed, the Phase II trial (NCT06092034) of RP-A501 for Danon disease restarts under an optimized dosing and immunomodulatory strategy.

In this video interview, Caroline Potts, general manager of sites and patient services at Medical Research Network (MRN), ...

Conducting Large Simple Trials to answer questions about "real-world" medical interventions is not a recent concept.